Learn more

PHERIN CORP

Overview
  • Total Patents
    80
About

PHERIN CORP has a total of 80 patent applications. Its first patent ever was published in 1991. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and medical technology are PATPHARMA ETS, WALL MONROE E and ROGER BELLON.

Patent filings per year

Chart showing PHERIN CORPs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Berliner David L 73
#2 Jennings-White Clive L 62
#3 Adams Nathan William 34
#4 Adams Nathan W 30
#5 Berliner D L 4
#6 Adams N W 4
#7 Jennings-White C L 3
#8 Adams William Nathan 3
#9 Monti-Bloch Louis 2
#10 Jennings White Clive L 2

Latest patents

Publication Filing date Title
US6140316A Estrene steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions
WO9803207A1 Steroids as neurochemical stimulators of the vno to alleviate symptoms of pms and anxiety
CN1225098A 19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function
WO9727887A1 Device and method for delivery of matter to the vomeronasal organ
US6057439A Steroids as neurochemical stimulators of the VNO to alleviate symptoms of PMS and anxiety
US5922699A 19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function
US5883087A Androstane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
US6066627A Steroids as neurochemical initiators of change in human blood levels of LH
PL319601A1 Hypothalamus action stimulating novel estrenes
US5994333A Pregnane and cholane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
US5925774A Estrenes for inducing hypothalamic effects
US5633392A Estrenes for inducing hypothalamic effects
US5969168A Androstanes for inducing hypothalamic effects
US5563131A Pregnane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
US5783571A Method of altering hypothalamic function by nasal administration of estrene steroids
NZ257218A Androstane steroid-containing medicament for nasal administration
NZ330376A Androstane steroid ligands as neurochemical initiators of change in human hypothalamic and autonomic function
TW289730B Pharmaceutical composition for alleviating the symptoms of psychoses, depression or anxiety comprising androstene steroids
US5303703A Combined neuroepithelial sample delivery electrode device and methods of using same